Arena Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch ARNA and buy or sell other stocks, options, and ETFs commission-free!

About ARNA

Clinical-stage biotech focused on cardiovascular, central nervous system, inflammatory and metabolic diseases. Their leading drug candidate is lorcaserin hydrochloride, which recently received positive data from a clinical trial.

CEO

Amit Dilip Munshi, MBA

CEOAmit Dilip Munshi, MBA

Employees

—

Employees—

Headquarters

Park City, Utah

HeadquartersPark City, Utah

Founded

1997

Founded1997

Employees

—

Employees—

ARNA Key Statistics

Market cap

6.17B

Market cap6.17B

Price-Earnings ratio

-9.87

Price-Earnings ratio-9.87

Dividend yield

—

Dividend yield—

Average volume

2.32M

Average volume2.32M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$100.00

52 Week high$100.00

52 Week low

$45.50

52 Week low$45.50

ARNA News

Yahoo Finance 18h

Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies ... - Yahoo Finance

DelveInsight Business Research LLP The dynamics of the inflammatory bowel disease market are anticipated to change in the coming years owing to the improvement...